Transaction
Adenia Partners' Majority Acquisition of Parkville Pharmaceuticals from Admaius Capital Partners and Founders
- Announced
- 26 January 2026
- Target
- Parkville Pharmaceuticals Egypt Limited
- Value
- Undisclosed
- Asset class
- Private Equity
- Type
- Investment, Exit
- Instrument
- Equity
- Lead investors
- Adenia Partners Limited
- Investors
- Adenia Partners Limited
- Sector
- Healthcare / Personal Products, Pharmaceuticals
- Markets
- Egypt
About the target
Parkville Pharmaceuticals Egypt Limited was founded in 2008. Headquartered in Cairo at 11B El Hegaz Square, El-Mohandessin, Infinity Towers, the company operates primarily in Egypt with export operations across Libya, Saudi Arabia, Kuwait, Dubai and Iraq. Core business activities include the development, manufacturing and distribution of pharmaceutical, cosmeceutical and nutraceutical products targeting skin care, hair care, wellness and therapeutic applications. The company manufactures over 125 individual products under multiple brand names, including StarVille, StrongVille, Bobai, Glamy Lab, Shaan, Seropipe, Super Kids and Sulfax.
Sources
- www.dailynewsegypt.com
- Partner Researchers